the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma

NCT05408221 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Rulonilimab+Lenvatinib
DRUG: Rulonilimab placebo +Lenvatinib

Sponsor

Shandong New Time Pharmaceutical Co., LTD